<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00382317</url>
  </required_header>
  <id_info>
    <org_study_id>ISO-44-009</org_study_id>
    <nct_id>NCT00382317</nct_id>
  </id_info>
  <brief_title>A Clinical Study of Iobitridol in Patients Undergoing Multislice Computed Tomography (CT) Abdominal Angiography</brief_title>
  <official_title>A Clinical Study of Iobitridol in Multislice CT Abdominal Angiography Indications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guerbet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guerbet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a clinical study of iobitridol in patients undergoing multislice CT (MSCT) abdominal
      angiography.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <condition>Diagnostic Imaging</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Iobitridol</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female having reached legal majority age and up to 85 years included.

          -  Scheduled for an aorta and abdominal arterial tree evaluation by MSCT, either for
             pre-therapeutic evaluation or for post-surgical control or follow-up (including
             patients with prosthetic vascular material).

          -  Female of childbearing potential must have effective contraception (contraceptive pill
             or intra-uterine device), or be surgically sterilised, or post-menopausal (minimum 12
             months amenorrhea) or must have a documented negative urine and/or blood pregnancy
             test at screening.

        Exclusion Criteria:

          -  Patients with overt non-compensated heart failure.

          -  Patients with hemodynamic instability.

          -  Patients with ESC (European Society of Cardiology)/ESH (European Society of
             Hypertension) grade 3 hypertension (SBP [systolic blood pressure) over or equal to 180
             mm Hg or DBP [diastolic blood pressure] over or equal to 110 mm Hg)

          -  Patients with known severe renal failure (defined as creatinine clearance &lt; 30 ml/min
             as calculated by the Cockroft and Gault formula).

          -  Patients who have received diuretic or biguanide treatment during the 48 hours
             preceding the MSCT scan.

          -  Patients with known thyreotoxicosis.

          -  Patients with history of immediate or delayed major hypersensitivity reaction to
             iodinated contrast media.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Corinne Dubourdieu, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Guerbet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AKH</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>France</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2006</study_first_submitted>
  <study_first_submitted_qc>September 28, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2006</study_first_posted>
  <last_update_submitted>November 25, 2008</last_update_submitted>
  <last_update_submitted_qc>November 25, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 26, 2008</last_update_posted>
  <keyword>MSCT indications</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

